P-values | ||||
---|---|---|---|---|
Source | Model 1 | Model 2 | Model 3 | Model 4 |
Baseline severity (BS) | <0.0001 | |||
Study (ST) | 0.15 | |||
Adverse event (AE) | 0.49 | |||
Treatment group (TG) | 0.033 | |||
AE*ST | 0.008 | 0.011 | 0.010 | 0.017 |
TG*AE | 0.15 | 0.13 | 0.13 | |
TG*ST | 0.80 | 0.79 | ||
TG*AE*ST | 0.69 | |||
Estimated effect of AE occurrence on spasticity NRS (95% CI) | Previous users: | −1.08 (−1.35 to −0.82) | ||
No previous use: | −1.20 (−1.38 to −1.01) | |||
Estimated difference: | −0.11 (−0.44 to 0.21) |